Cellestial Health logo
cellestialhealth.com
Actively hiring
Biologics & Biosimilars
Drug Discovery
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
Cambridge Enterprise, Zinc
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Zinc 
SFC Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing RTN-001 and next-generation therapies for uncontrolled…
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Agile GxP Technologies want to accelerate the delivery of new therapies to patients by providing transformative technology to cGxP…
Xylo is pioneering next-generation therapeutics designed to rewire neural circuits and restore brain function. Discover our innovative…
Transforming the Future of Neuropsychiatry. Draig Therapeutics is developing transformative, best-in-class neuropsychiatric therapies to…
Overview
Paradigm Shift for Parkinson’s.. Cellestial Health is a preclinical biopharmaceutical company transforming the future of brain disease therapies by focusing on astrocytic networks, an often-overlooked yet critical component of brain function.